Surgical Care for Gastro-Intestinal Stromal Tumours
Patnala Mohan Patro*
Former Professor and HOD of Surgery, GIMSR, GITAM University, India
*Corresponding Author: Patnala Mohan Patro, Former Professor and HOD of Surgery, GIMSR, GITAM University, India.
July 21, 2022; Published:
Gastrointestinal stromal tumors (GISTs) account for less than 1% of GI tumors, but they are the most common mesenchymal neoplasms of the GI tract . GISTs are usually found in the stomach or small intestine but can occur anywhere along the GI tract and rarely have extra-GI involvement.
Surgery is the definitive therapy for localized GISTs . Despite the proven success of Imatinib and other newer tyrosine kinase inhibitors, surgical resection remains the treatment of choice and offers the only chance for cure of GIST .
- PDQ Adult Treatment Editorial Board. “Gastrointestinal Stromal Tumors Treatment (Adult) (PDQ®)”. Health Professional Version (2020).
- Casli PG., et al. “ESMO Guidelines Committee, EURACAN and GENTURIS. Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up”. Annals of Oncology 1 (2022): 20-33.
- Guo Y., et al. “The Role of Surgical Resection Following Tyrosine Kinase Inhibitors Treatment in Patients with Advanced Gastrointestinal Stromal Tumors: A Systematic Review and Meta-analysis”.Journal of Cancer 23 (2019): 5785-5792.
- Katai H., et al. “Wedge resection of the stomach for gastric leiomyosarcoma”. British Journal of Surgery4 (1997): 560-561.
- National Comprehensive Cancer Network. “NCCN Clinical Practice Guidelines in Oncology: Gastrointestinal Stromal Tumors (GISTs)”. NCCN.
- Zhao Y., et al. “Retrospective Comparison of Endoscopic Full-Thickness Versus Laparoscopic or Surgical Resection of Small (≤ 5 cm) Gastric Gastrointestinal Stromal Tumors”. Journal of Gastrointestinal Surgery12 (2019): 2714-2721.
- Eisenberg BL and Judson I. “Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy”.Annals of Surgical Oncology5 (2004): 465-475.
- Rutkowski P., et al. “Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate”. Journal of Surgical Oncology4 (2016): 304-311.
- Chen H., et al. “Complete hepatic resection of metastases from leiomyosarcoma prolongs survival”. Journal of Gastrointestinal Surgery 2 (1998): 151-155.